
Peter G. Collin, MD
Advertisement
Collin is a second-year infectious diseases fellow at Beth Israel Deaconess Medical Center.
Articles by Peter G. Collin, MD


The significance of antiretroviral therapy (ART) has been a game changer for people living with HIV (PLWH). Still, there are some cardiovascular risks associated with different ART classes—particularly protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs). Authors review a piece in the literature around this area of study.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Clears First At-Home Diagnostic for RSV, Influenza, and COVID-19 in Adults, Young Infants
2
CDC ACIP Workgroup Reviewing FDA-Approved HPV Vaccines
3
Assessing Social Determinants of Health with Treatment Failure In UTIs
4
Antifungal Earns FDA QIDP and Fast Track Designations Amid Rising Antifungal Resistance
5
